Institute for Evaluative Research in Orthopedic Surgery, University of Bern, Stauffacherstrasse 78, 3014 Bern, Switzerland.
Eur Spine J. 2010 Dec;19(12):2190-9. doi: 10.1007/s00586-010-1550-3. Epub 2010 Aug 15.
The SWISSspine registry is the first mandatory registry of its kind in the history of Swiss orthopaedics and it follows the principle of "coverage with evidence development". Its goal is the generation of evidence for a decision by the Swiss federal office of health about reimbursement of the concerned technologies and treatments by the basic health insurance of Switzerland. Recently, developed and clinically implemented, the Dynardi total disc arthroplasty (TDA) accounted for 10% of the implanted lumbar TDAs in the registry. We compared the outcomes of patients treated with Dynardi to those of the recipients of the other TDAs in the registry. Between March 2005 and October 2009, 483 patients with single-level TDA were documented in the registry. The 52 patients with a single Dynardi lumbar disc prosthesis implanted by two surgeons (CE and OS) were compared to the 431 patients who received one of the other prostheses. Data were collected in a prospective, observational multicenter mode. Surgery, implant, 3-month, 1-year, and 2-year follow-up forms as well as comorbidity, NASS and EQ-5D questionnaires were collected. For statistical analyses, the Wilcoxon signed-rank test and chi-square test were used. Multivariate regression analyses were also performed. Significant and clinically relevant reduction of low back pain and leg pain as well as improvement in quality of life was seen in both groups (P < 0.001 postop vs. preop). There were no inter-group differences regarding postoperative pain levels, intraoperative and follow-up complications or revision procedures with a new hospitalization. However, significantly more Dynardi patients achieved a minimum clinically relevant low back pain alleviation of 18 VAS points and a quality of life improvement of 0.25 EQ-5D points. The patients with Dynardi prosthesis showed a similar outcome to patients receiving the other TDAs in terms of postoperative low back and leg pain, complications, and revision procedures. A higher likelihood for achieving a minimum clinically relevant improvement of low back pain and quality of life in Dynardi patients was observed. This difference might be due to the large number of surgeons using other TDAs compared to only two surgeons using the Dynardi TDA, with corresponding variations in patient selection, patient-physician interaction and other factors, which cannot be assessed in a registry study.
瑞士脊柱注册研究是瑞士矫形外科史上首个强制性注册研究,它遵循“证据开发覆盖”原则。其目标是为瑞士联邦卫生局决定是否对瑞士基本医疗保险涵盖相关技术和治疗方法提供证据。最近,在注册研究中,开发和临床应用的 Dynardi 全椎间盘置换术(TDA)占植入腰椎 TDA 的 10%。我们将接受 Dynardi 治疗的患者的结果与注册研究中接受其他 TDA 的患者的结果进行了比较。2005 年 3 月至 2009 年 10 月,该注册研究共记录了 483 例单节段 TDA 患者。比较了由两位外科医生(CE 和 OS)植入 Dynardi 腰椎椎间盘假体的 52 例患者和接受其他假体的 431 例患者。数据以前瞻性、观察性多中心模式收集。收集了手术、植入物、术后 3 个月、1 年和 2 年随访表以及合并症、NASS 和 EQ-5D 问卷。采用 Wilcoxon 符号秩检验和卡方检验进行统计学分析。还进行了多变量回归分析。两组患者的腰痛和腿痛均显著减轻(P < 0.001),生活质量均显著改善(P < 0.001)。两组术后疼痛水平、术中及随访并发症或再次住院行翻修术无差异。然而,Dynardi 患者中达到腰痛缓解 18 个 VAS 点和生活质量提高 0.25 EQ-5D 点的最小临床相关缓解的患者比例明显更高。Dynardi 假体组患者的术后腰痛和腿痛、并发症和翻修术与接受其他 TDA 的患者相似。Dynardi 患者达到腰痛和生活质量最小临床相关改善的可能性更高。这种差异可能是由于使用 Dynardi TDA 的外科医生数量较少,而使用其他 TDA 的外科医生数量较多,导致患者选择、医患互动和其他因素存在差异,而这些因素在注册研究中无法评估。